文献速递前列腺癌

前列腺癌选择性骨扫描分期评估——现行策略的外部验证与决策曲线分析

Evaluation of selective bone scan staging in prostate cancer - external validation of current strategies and decision-curve analysis.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2022-03-14

研究在2005至2019年诊断的10721例前列腺癌人群队列中外部验证11个预测模型,以净获益为主要结局,比较不同保守度与容忍度下选择性骨扫描分期的策略。结果显示按EAU 2020指南仅扫描高危患者可在最大偏好比范围内提供最大净获益,其他策略在特定范围内更优。

要点

  • 偏好比小于1:39(NWT大于40)时,全部扫描的净获益高于选择性分期。
  • 偏好比1:39至3:97(NWT 33-40)时,EAU 2020指南推荐是最佳策略。
  • 偏好比3:97至7:93(NWT 14-33)时,仅扫描EAU高危患者更优。

核心结论

  • 识别出三种选择性分期策略优于其他所有策略,但各自适用的保守度与容忍度范围不同。
  • 仅扫描EAU高危患者在最大偏好比范围和情景下提供最大净获益。
  • 根据当地医疗系统的保守度和容忍度,其他选项可能更优。

研究设计与样本

  • 在2005至2019年诊断的10721例前列腺癌患者的人群队列中外部验证11个预测模型。
  • 主要结局为净获益,在不同保守度与容忍度平衡下评估,以偏好比和需检测人数(NWT)表示。
  • 次要结局包括校准斜率、大范围校准(截距)和受试者工作特征曲线下面积(AUC)衡量的区分度。

主要发现

  • 偏好比小于1:39(NWT大于40)时,全部扫描的净获益大于选择性分期。
  • 偏好比1:39至3:97(NWT 33-40)时,EAU 2020指南推荐是最佳方法。
  • 偏好比3:97至7:93(NWT 14-33)时,仅扫描EAU高危患者更优。
  • 偏好比7:93至1:9(NWT 10-13)时,仅扫描Gnanapragasam Group 5患者最佳。
  • 所有模型区分度相似且一般(AUC 0.68-0.80),但大多数校准较差。

关键数值与推荐

  • 偏好比小于1:39(NWT大于40):全部扫描净获益更高。
  • 偏好比1:39至3:97(NWT 33-40):EAU 2020指南推荐最佳。
  • 偏好比3:97至7:93(NWT 14-33):仅扫描EAU高危患者更优。
  • 偏好比7:93至1:9(NWT 10-13):仅扫描Gnanapragasam Group 5患者最佳。
  • 所有模型AUC 0.68-0.80,区分度相似且一般,大多数校准较差。

临床怎么用

  • 仅扫描EAU高危患者在最大偏好比范围和情景下提供最大净获益,但其他选项可能根据当地医疗系统的保守度和容忍度更优。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recommendations for staging newly diagnosed prostate cancer patients vary between guidelines and literature. METHODS: Our objective was to validate and compare prediction models selecting newly diagnosed prostate cancer patients for bone scan staging. To achieve this, we validated eleven models in a population-based cohort of 10,721 patients diagnosed with prostate cancer between 2005 and 2019. The primary outcome was net-benefit. This was assessed at different balances of conservatism and tolerance, represented by preference ratio and number-willing-to-test (NWT). Secondary outcomes included calibration slope, calibration-in-the-large (intercept), and discrimination measured by Area-under-the-receiver-operator-characteristics curve (AUC). RESULTS: For preference ratios less than 1:39 (NWT greater than 40), scanning everyone provided greater net-benefit than selective staging. For preference ratios 1:39 to 3:97 (NWT 33-40), the European Association of Urology (EAU) 2020 guideline recommendation was the best approach. For preference ratios 3:97-7:93 (NWT 14-33), scanning EAU high-risk patients only was preferable. For preference ratios 7:93-1:9 (NWT 10-13), scanning only Gnanapragasam Group 5 patients was best. All models had similar fair discrimination (AUCs 0.68-0.80), but most had poor calibration. CONCLUSIONS: We identified three selective staging strategies that outperformed all other approaches but did so over different ranges of conservatism and tolerance. Scanning only EAU high-risk patients provided the greatest net-benefit over the greatest range of preference ratios and scenarios, but other options may be preferable depending upon the local healthcare system's degree of conservatism and tolerance.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Hiwase MD, Jay A, Bulamu N, et al. Evaluation of selective bone scan staging in prostate cancer - external validation of current strategies and decision-curve analysis. Prostate Cancer Prostatic Dis. 2022. PMID: 35288662. doi:10.1038/s41391-022-00515-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。